CASE COMMENTS: ANTICOMPETITIVE AGREEMENTS - FORECLOSURE OF COMPETITORS - FINE

Foreclosure of competitors : The European Commission fines a pharmaceutical laboratory and its five competitors for having agreed to protect its generic core (Servier)

KEYWORDS
Reference

Comm. eur., 9 juillet 2014, communiqué de presse IP/14/799

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The third decision adopted by the European Commission in a "pay-for-delay" dossier after the Lundbeck decisions of 19 June 2013(COMP/ AT. 39226) and Novartis of 10 December 2013 (COMP/ AT. 39226).(COMP/.

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.